State Street’s Biotricity, Inc. Common Stock BTCY Stock Holding History

State Street’s Portfolio BTCY Stock Details BTCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-22,548	Closed	-$20.3K	–	4390
2024 Q2	$20.3K	Hold	22,548	–	–	﹤0.01%	4275
2024 Q1	$33.4K	Hold	22,548	–	–	﹤0.01%	4226
2023 Q4	$26.6K	Hold	22,548	–	–	﹤0.01%	4305
2023 Q3	$47.1K	Sell	22,548 -1	-0%	-$2	﹤0.01%	4300
2023 Q2	$86.3K	Hold	22,549	–	–	﹤0.01%	4276
2023 Q1	$62.9K	Hold	22,549	–	–	﹤0.01%	4447
2022 Q4	$61K	Hold	22,549	–	–	﹤0.01%	4511
2022 Q3	$108K	Hold	22,549	–	–	﹤0.01%	4446
2022 Q2	$239K	Hold	22,549	–	–	﹤0.01%	4121
2022 Q1	$307K	Buy	22,549 +19,266	+587%	+$334K	﹤0.01%	4234
2021 Q4	$78K	Buy	+3,283	New	+$77.4K	﹤0.01%	4623

Other funds holding BTCY

SFCL

Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PWA

Provenance Wealth Advisors Fort Lauderdale, Florida $1.05B AUM 18.67% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

State Street's BTCY Position: Q3 2024 in Review

State Street sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2024, closing a stake of 22,548 shares — an estimated $20.3K sold.

State Street first reported a position in BTCY in Q4 2021 and held it in 11 quarters. The position peaked at $307K in Q1 2022. 5 funds tracked by Wall St. Rank hold BTCY as of Q3 2024.

State Street reported no remaining Biotricity, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
State Street sold 22,548 Biotricity, Inc. Common Stock shares in Q3 2024, an estimated $20.3K.
State Street first reported a position in Biotricity, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
State Street's Biotricity, Inc. Common Stock position peaked at $307K in Q1 2022.
5 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2024.

Based on State Street's 13F filing for Q3 2024, filed 14 Nov 2024.